STERIS plc announced that Walt Rosebrough, President and CEO, has announced his intention to step down on July 29, 2021, in conjunction with the company’s Annual General Meeting. Mr. Rosebrough will remain as CEO Emeritus and Senior Advisor to STERIS’s leadership and Board for the next two years. STERIS’s Board of Directors has unanimously appointed Dan Carestio will succeed Mr. Rosebrough as President and CEO, effective July 29, 2021.
STERIS plc is one of the world's leading providers of infection control solutions and procedural services. Net sales break down by activity as follows:
- sales of infection control solutions (62.9%): including cleaning and sterilization chemicals, accessories for gastrointestinal procedures, washers, sterilizers and operating room equipment (including surgical tables, lighting and connectivity solutions). In addition, the group offers specialized healthcare services (sterilization services, instrument and endoscope repair and maintenance and customized process improvement consulting in acute care hospitals);
- development of applied sterilization solutions (22.1%): contract development of sterilization modalities and laboratory testing services for more than 50 sterilization and laboratory facilities worldwide;
- manufacturing of consumables and maintenance equipment (15%): dedicated to pharmaceutical manufacturers.
Net sales by source of income are divided into sales of services (53.5%), sales of consumables (23.4%) and sales of equipment (23.1%).
Net sales are distributed geographically as follows Ireland (2.3%), the United States (71.7%) and other (26%).
STERIS PLC 
